careers & recruitment

CAREER FEATURE Second-quarter biotech job picture A quarterly snapshot of job expansions, reductions and availability in the biotech and pharma sectors.

he second quarter of 2020 saw several pharma company the former facility for $890 million. The current buildout expansions. In April, Baxter International said it would includes adding six mammalian cell bioreactors, installing a Thire up to 2,000 employees globally, including 800 in the fill/finish production line with an expected capacity of 35 million United States, in response to greater demand for medical devices units per year, and setting up a new packaging line for autoinjectors due to the coronavirus pandemic. with automatic labeling. The site has already received a commitment In June, Fujifilm Diosynth announced a $928 million investment from the COVID-19 Therapeutics Accelerator, which has reserved to double biologics production capacity at its Hillerød, Denmark future manufacturing capacity. site by 2023. The move comes a year after the contract development On the negative side, Sage Therapeutics announced a major and manufacturing arm of the Japanese conglomerate acquired restructuring following the failure of a phase 3 study. In April, the biotech laid off 340 employees, slightly more than half its workforce. And in June, said it would eliminate 1,700 European Table 1 | Who’s hiring? Advertised openings at the 25 largest jobs, including 1,000 in France, as part of a $1.8 billion cost biotech companies cutting over the next two years. It also announced it would invest Companya Number of Number of advertised openingsb $440 million to build a new production site in France employees that would create 200 jobs. Monster LinkedIn Biospace Advertised biotechnology and pharmaceutical sector jobs in the 21,500 75 184 152 job databases tracked by Nature Biotechnology were down in the 11,800 6 332 149 second quarter of 2020 (Tables 1 and 2) compared with the previous ❐ bioMérieux 11,200 29 17 0 quarter (Nat. Biotechnol. 38, 651, 2020). Biocon 10,000 14 532 0 Celgene 8,852 180 0 165 Table 2 | Advertised job openings at the ten largest pharma IDEXX Laboratories 8,377 45 71 0 companies Biogen 7,800 20 491 0 Companya Number of Number of advertised openingsb Regeneron Pharmaceuticals 7,400 43 359 403 employees Monster LinkedIn Biospace Illumina 7,300 166 124 0 Novozymes 6,279 0 2 0 Johnson & Johnson 135,100 13 727 0 Opko Health 5,690 0 0 0 Bayer 115,500 16 237 0 Endo Pharmaceuticals 2,910 135 28 0 Novartis 108,000 403 304 0 BioMarin Pharmaceutical 2,849 29 116 0 Sanofi 104,230 7 382 0 BGI Genomics 2,846 12 0 0 103,000 3 847 0 2,656 3 61 0 GlaxoSmithKline 95,490 2 704 0 GenScript Biotech 2,620 0 0 8 Roche 94,440 2 450 0 Evotec 2,617 0 4 22 92,400 4 309 0 2,500 161 149 0 Sinopharm 69,720 0 0 0 2,400 34 97 0 Merck & Co. 69,000 1 361 0 2,300 55 62 0 Total 451 4,315 0 a b Amphastar Pharmaceuticals 2,078 0 7 0 Data obtained from Statista. As searched on Monster.com, LinkedIn.com and Biospace.com, 6 July 2020. Jobs may overlap. BeiGene 2,070 0 93 0 CK Life Sciences 1,785 0 0 0 Emergent BioSolutions 1,705 68 185 185 Michael Francisco Biotest 1,663 0 0 0 Senior Editor, Nature Biotechnology. Total 1,075 2,914 1,084 aAs defined in Nature Biotechnology’s survey of public companies (36, 576–584, 2018). bAs searched Published online: 5 August 2020 on Monster.com, LinkedIn.com and Biospace.com, 6 July 2020. Jobs may overlap. https://doi.org/10.1038/s41587-020-0622-0

Nature Biotechnology | VOL 38 | August 2020 | 1003–1004 | www.nature.com/naturebiotechnology 1003